GE HealthCare (Nasdaq:GEHC) today announced the appointment of Dr. Taha Kass-Hout as its first Chief Technology Officer (CTO).
Kass-Hout’s responsibilities include leading a new GE spin-off science and technology organization. He reports directly to Peter Arduini, President and CEO of GE HealthCare.
The role will include driving the company’s D3 Precision Care strategy, according to a news release. This framework highlights smart devices from GE HealthCare. D3 brings together data and insights with the goal of optimizing clinical and patient journeys. This will enhance the company’s ability to enable precision care, the company said.
“GE Healthcare has a strong track record of industry-first technology and an innovation pipeline of products focused on improving patient care,” said Arduini. Taha brings outstanding clinical and technical experience.Under his leadership, our new scientific research organization will strengthen end-to-end collaboration within key research and product development segments to shape the future of healthcare. We deliver innovative solutions that enhance our ability to transform and enable precision care.”
About Dr. Taha Kashout
Prior to joining GE HealthCare, Kass-Hout served as Vice President, Machine Learning and CMO at Amazon and Amazon Web Services. His roles there included establishing and leading health AI strategies and technologies.
In addition, Kass-Hout has held leadership roles at the FDA and served two terms in the Obama administration. He became the FDA’s first Chief Health Information Officer. Kass-Hout also served as director of informatics and informatics at the US Centers for Disease Control and Prevention.
“I am honored to join the GE Healthcare team as a clinician, civil servant, digital health and ML expert, who will lead digital transformation and improve outcomes for patients and providers. The passion, purpose and commitment to do is clearly aligned with mine.” Kashout. “We have an incredible opportunity to achieve GE Healthcare’s purpose of creating a world without limits in healthcare and establishing new frontiers to advance diagnostics and personalized care for people, and what lies ahead. I am excited about.”
About the CTO role at GE Healthcare
Kass-Hout’s new role includes partnerships with four GE HealthCare business units: Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The company also expects him to work collaboratively with various regions and engineering and machine learning teams.
GE HealthCare said its new science and technology organization is working toward its goal of advancing the future of healthcare. This includes providing personalized care throughout the patient journey. The company says its team has innovative researchers for the healthcare ecosystem.
They are also looking to execute their digital strategy, from software development to device integration to cloud adoption. According to GE HealthCare, the company’s regional research team helps connect and execute external engagement strategies.
“One of the biggest dilemmas our customers face is delivering personalized care in the right way and getting the right diagnosis with the right data,” said Arduini. With the D3 Precision Care Framework, GE HealthCare empowers customers to collaborate across their healthcare systems to develop personalized approaches to solving diagnostic challenges and improving patient outcomes while increasing productivity. We are uniquely positioned to help you bring your data to life. ”
For those who missed the spin-off news
Yesterday, January 4, 2023, the spin-off of GE’s healthcare business was officially announced. The company began trading on the Nasdaq market and joined the S&P 500.
GE has announced plans to spin off its medical technology business in November 2021. The Board of Directors has approved the transaction in November 2022. GE has prorated approximately 80.1% of outstanding GE Healthcare shares to his GE shareholders. We own approximately 19.9% of the outstanding common stock of GE HealthCare.
Chicago-based GE HealthCare ranks #6 among sister sites Medical design and outsourcingBig 100 ranking of the world’s largest medical device companies. Annual sales are approximately $18 billion. The company also registers more than $1 billion in R&D spending annually and has 51,000 employees.
GEHC shares were up 0.9% to $61 a share in today’s morning trading. MassDevice’s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, saw him up 7.4%.
